Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the target of a large increase in short interest in August. As of August 14th, there was short interest totaling 113,543 shares, an increase of 343.9% from the July 30th total of 25,578 shares. Based on an average trading volume of 141,285 shares, the days-to-cover ratio is presently 0.8 days. Currently, 1.7% of the company’s stock are short sold.
Oxbridge Re Price Performance
Shares of OXBR stock traded up $0.01 on Friday, hitting $1.28. The stock had a trading volume of 643 shares, compared to its average volume of 78,272. The business has a 50 day moving average of $1.35 and a 200 day moving average of $1.09. Oxbridge Re has a 12-month low of $0.66 and a 12-month high of $2.86. The stock has a market cap of $10.46 million, a price-to-earnings ratio of 64.28 and a beta of 1.94.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The firm had revenue of $0.94 million during the quarter, compared to the consensus estimate of $1.10 million. As a group, research analysts expect that Oxbridge Re will post -0.08 earnings per share for the current fiscal year.
Institutional Trading of Oxbridge Re
Wall Street Analyst Weigh In
OXBR has been the subject of a number of recent research reports. Maxim Group decreased their price objective on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a report on Tuesday, June 16th. Weiss Ratings upgraded Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. Finally, Zacks Research cut Oxbridge Re from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company. According to MarketBeat.com, Oxbridge Re presently has a consensus rating of “Reduce” and a consensus target price of $3.00.
Read Our Latest Report on OXBR
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
- Meta’s $18 Billion Settlement May Be a Win for Investors
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
